One of the main factors of uncontrolled cell proliferation and CDK4/6 inhibitor resistance frequently seen in breast tumors is the deregulation of the cyclin D-CDK4/6-INK4-RB axis, upstream response, and downstream bypass mechanisms (Li et al., 2020). The gene discussed is CDK4; the disease is breast neoplasm.